AMGN vs POST · P/E 24, rev $36.75B vs P/E 15, rev $8.16B
Amgen Inc (AMGN) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the AMGN and POST stock pages for the full models.
Not investment advice.